Recent 13F filings as of December 2025 show that 13 institutional investors hold a position in Ernexa Therapeutics Inc. (NASDAQ:ERNA).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 35,922 | 24,775 | 222.26% | $43,106.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 23,617 | 3,164 | 15.47% | $28,340.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 12,625 | 12,625 | 0.00% | $15.00 |
| Sippican Capital Advisors | 31 Dec, 2025 | 10,000 | 0 | 0.00% | $12,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 820 | 0 | 0.00% | $984.00 |
| Fortitude Family Office, LLC | 31 Dec, 2025 | 804 | 804 | 0.00% | $965.00 |
| UBS Group AG | 31 Dec, 2025 | 600 | 600 | 0.00% | $720.00 |
| ASSETMARK, INC | 31 Dec, 2025 | 133 | 0 | 0.00% | $160.00 |
| BANK OF AMERICA CORP /DE/ | 31 Dec, 2025 | 34 | 1 | 3.03% | $41.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 30 | -47 | -61.04% | $36.00 |
| BNP PARIBAS FINANCIAL MARKETS | 31 Dec, 2025 | 10 | 0 | 0.00% | $12.00 |
| MONTAG A & ASSOCIATES INC | 31 Dec, 2025 | 8 | 0 | 0.00% | $10.00 |
| Activest Wealth Management | 31 Dec, 2025 | 3 | 0 | 0.00% | $4.00 |